Smoking and gastrointestinal cancer patients—is smoking cessation an attainable goal?

Background and Objectives Negative consequences of tobacco use during cancer treatment are well‐documented but more in‐depth, patient‐level data are needed to understand patient beliefs about continued smoking (vs cessation) during gastrointestinal (GI) cancer treatment. Methods We conducted semi‐structured interviews with 10 patients who were active smokers being treated for GI cancers and 5 caregivers of such patients. All interviews were audio‐recorded, transcribed verbatim, and uploaded to NVivo. We consensus coded data inductively using conventional content analysis and iteratively developed our codebook. We developed data matrices to categorize the themes regarding patient perspectives on smoking as well as presumed barriers to smoking cessation during active therapy. Results Our interviews revealed three consistent themes: (a) Smoking cessation is not necessarily desired by many patients who have received a cancer diagnosis; (b) Failure in past quit attempts may lead to feelings of hopeless about future attempts, especially during cancer treatment; (c) Patients perceived little to no access to smoking cessation treatment at the time of their cancer diagnosis. Conclusions Well‐designed systemic changes that promote the positive and efficacious effects of quitting smoking during cancer treatment, and that provide barrier‐free access to such treatments may be helpful in promoting tobacco‐free behavior during cancer treatment.